Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.4400
0.00 (0.00%)
At close: Jan 30, 2026, 4:00 PM EST
0.4563
+0.0163 (3.70%)
After-hours: Jan 30, 2026, 7:47 PM EST

Mereo BioPharma Group Revenue

Mereo BioPharma Group had revenue of $500.00K in the twelve months ending September 30, 2025, down -50.00% year-over-year.

Revenue (ttm)
$500.00K
Revenue Growth
-50.00%
P/S Ratio
139.20
Revenue / Employee
$13,889
Employees
36
Market Cap
70.02M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202149.37M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pelthos Therapeutics7.41M
Kazia Therapeutics1.20M
ImageneBio800.00K
Coeptis Therapeutics Holdings501.00K
Entera Bio124.00K
Revenue Rankings

MREO News

More News